Exponent, Inc. (NASDAQ:EXPO - Get Free Report) CEO Catherine Corrigan sold 4,896 shares of the firm's stock in a transaction on Thursday, August 14th. The stock was sold at an average price of $71.09, for a total value of $348,056.64. Following the completion of the sale, the chief executive officer directly owned 81,342 shares of the company's stock, valued at $5,782,602.78. The trade was a 5.68% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.
Exponent Price Performance
NASDAQ EXPO traded up $0.3050 during trading on Wednesday, hitting $69.9050. The company's stock had a trading volume of 38,877 shares, compared to its average volume of 316,259. The company has a market cap of $3.53 billion, a PE ratio of 34.99 and a beta of 0.89. The business's 50 day simple moving average is $73.13 and its 200-day simple moving average is $78.41. Exponent, Inc. has a fifty-two week low of $63.81 and a fifty-two week high of $115.75.
Exponent (NASDAQ:EXPO - Get Free Report) last released its earnings results on Thursday, July 31st. The business services provider reported $0.52 EPS for the quarter, topping analysts' consensus estimates of $0.48 by $0.04. The company had revenue of $132.87 million during the quarter, compared to analysts' expectations of $130.82 million. Exponent had a net margin of 18.35% and a return on equity of 24.19%. Exponent's revenue for the quarter was up 7.3% on a year-over-year basis. During the same period last year, the business earned $0.57 EPS. Analysts expect that Exponent, Inc. will post 1.98 EPS for the current fiscal year.
Exponent Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Friday, September 19th. Shareholders of record on Friday, September 5th will be given a dividend of $0.30 per share. The ex-dividend date of this dividend is Friday, September 5th. This represents a $1.20 dividend on an annualized basis and a yield of 1.7%. Exponent's payout ratio is currently 60.00%.
Institutional Investors Weigh In On Exponent
A number of institutional investors and hedge funds have recently modified their holdings of the company. Franklin Resources Inc. lifted its position in Exponent by 5.4% during the fourth quarter. Franklin Resources Inc. now owns 3,710 shares of the business services provider's stock valued at $331,000 after purchasing an additional 189 shares during the period. Bank of Montreal Can lifted its position in Exponent by 1.5% during the fourth quarter. Bank of Montreal Can now owns 8,747 shares of the business services provider's stock valued at $779,000 after purchasing an additional 131 shares during the period. Barclays PLC lifted its position in Exponent by 88.5% during the fourth quarter. Barclays PLC now owns 181,921 shares of the business services provider's stock valued at $16,209,000 after purchasing an additional 85,395 shares during the period. First Trust Advisors LP lifted its holdings in shares of Exponent by 74.1% in the 4th quarter. First Trust Advisors LP now owns 52,439 shares of the business services provider's stock valued at $4,672,000 after buying an additional 22,323 shares during the period. Finally, MetLife Investment Management LLC lifted its holdings in shares of Exponent by 8.3% in the 4th quarter. MetLife Investment Management LLC now owns 58,331 shares of the business services provider's stock valued at $5,197,000 after buying an additional 4,461 shares during the period. Institutional investors and hedge funds own 92.37% of the company's stock.
About Exponent
(
Get Free Report)
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.
Further Reading

Before you consider Exponent, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exponent wasn't on the list.
While Exponent currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.